Cadex Genomics Builds Out Leadership Team with Election of Kathy Hibbs to Board as an Independent Director

Hibbs brings more than 25 years of legal and management expertise in clinical diagnostic market segment to Cadex Genomics!

REDWOOD CITY, Calif. – October 18, 2019 – Cadex Genomics, developers of a real-time cancer therapy monitoring diagnostic, Alibrex, today announced the election of Kathy Hibbs, Esq. as an independent director.

Hibbs is the chief legal and regulatory officer at 23andMe. Prior to joining 23andMe, Hibbs served as senior vice president and general counsel, responsible for the legal, regulatory and business development functions at Genomic Health, Inc. Hibbs has also held related posts at Monogram Biosciences Inc., and Varian Medical Systems, Inc.

Hibbs is active in several industry groups, including AdvaMed and the Personalized Medicine Coalition (PMC). Hibbs holds a Juris Doctorate from the University of California, Hastings School of Law and a Bachelor of Arts in political science from the University of California, Riverside.

We are extremely pleased to have Kathy join our board,” said Bill Haack, president and CEO of Cadex Genomics. “Kathy brings a depth of leadership, knowledge and experience that will be invaluable to us as we approach the commercialization phase of the company.”

“Cadex Genomics is taking a novel and compelling approachto cancer therapy monitoring,” said Kathy Hibbs, chief legal and regulatory officer for 23andMe. “I am excited to join such a dynamic team at this pivotal point in the company’s growth.”

About Alibrex

Alibrex is a patented technology that detects, with great analytical precision, retrotransposon elements found on all 23 chromosomes. Alibrex enables testing with most tumor types. Alibrex is based on qPCR technology enabling fast turnaround time. 

About Cadex Genomics

Cadex Genomics is a privately held molecular diagnostic assay company based in Redwood City, California that is improving cancer patient outcomes by providing physicians with better diagnostic tools to guide treatment. For more information, please visit our website https://cadexgenomics.com. Alibrex and Cadex Genomics are trademarks of Cadex Genomics, Corp.

Cadex Genomics Media Contact:

Greg Schafer, Chief Commercial Officer
+1.650.292.2819
media@cadexgenomics.com

Media Contact
Company Name: Cadex Genomics, Corp
Contact Person: Tom Stitt
Email: Send Email
Phone: 6507047297
Address:541 Jefferson Avenue, Ste 100
City: Redwood City
State: California
Country: United States
Website: https://cadexgenomics.com